LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 18.98 | 27.76 | 1306 | 941 | 1.3877 | 1.1331 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 20.68 | 27.76 | 953 | 1119 | 0.8517 | 0.9407 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 20.68 | 27.76 | 1025 | 1119 | 0.9160 | 0.9674 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 20.68 | 27.76 | 56 | 1119 | 0.0500 | 0.1406 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 20.68 | 27.76 | 1095 | 1119 | 0.9786 | 0.9919 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 20.68 | 27.76 | 1201 | 1119 | 1.0733 | 1.0267 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 20.68 | 27.76 | 1339 | 1119 | 1.1966 | 1.0685 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 22.39 | 27.76 | 999 | 1305 | 0.7651 | 0.9059 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 22.39 | 27.76 | 1053 | 1305 | 0.8065 | 0.9240 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 22.39 | 27.76 | 261 | 1305 | 0.1999 | 0.4969 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 22.39 | 27.76 | 1099 | 1305 | 0.8417 | 0.9389 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 22.39 | 27.76 | 1277 | 1305 | 0.9780 | 0.9920 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 22.39 | 27.76 | 1372 | 1305 | 1.0508 | 1.0179 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 24.09 | 27.76 | 1018 | 1461 | 0.6965 | 0.8774 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 24.09 | 27.76 | 1071 | 1461 | 0.7327 | 0.8942 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 24.09 | 27.76 | 320 | 1461 | 0.2189 | 0.5335 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 24.09 | 27.76 | 1139 | 1461 | 0.7793 | 0.9147 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 24.09 | 27.76 | 1334 | 1461 | 0.9127 | 0.9683 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 24.09 | 27.76 | 1425 | 1461 | 0.9749 | 0.9911 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 25.79 | 27.76 | 1054 | 1605 | 0.6566 | 0.8613 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 25.79 | 27.76 | 1101 | 1605 | 0.6859 | 0.8753 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 25.79 | 27.76 | 968 | 1605 | 0.6031 | 0.8345 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 25.79 | 27.76 | 1184 | 1605 | 0.7376 | 0.8987 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 25.79 | 27.76 | 1399 | 1605 | 0.8716 | 0.9536 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 25.79 | 27.76 | 1465 | 1605 | 0.9127 | 0.9690 | MN20160318_Q01 | L08 |